Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Aegle, Bayer, Biomea, Biora, Clene, Curevo, Cybin, Fate, Highfield, Novartis, Novo Nordisk, Okyo, Oncternal, Oryzon, Pepgen, Pulmatrix, Tiziana, Vertex, Vincerx, Xilio.